Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 30, 1999

Study Completion Date

October 31, 1999

Conditions
Osteoarthritis
Interventions
DRUG

Buprenorphine transdermal delivery system

Trial Locations (22)

16635

Altoona Center for Clinical Research, Duncansville

27103

PW Clinical Research, LLC, Winston-Salem

32216

Physicians Research Associates Jacksonville, Jacksonville

32605

Gainesville Clinical Research Center, Gainesville

32720

University Clinical Research, DeLand

33024

University Clinical Research, Inc., Pembroke Pines

33331

Gold Coast Research, Inc., Weston

33761

Tampa Bay Medical Research, Inc., Clearwater

38120

Mid-South Clinical Research Institute, Memphis

45431

New Century Research Center, Ltd., Beaverbrook

47714

MediSphere Medical Research Center, LLC, Evansville

49009

Westside Family Medical Center, Kalamazoo

64114

Center for Pharmaceutical Research, Kansas City

84102

Advanced Clinical Research, Salt Lake City

85008

Hawthorne & York, International, Ltd., Phoenix

85023

Arizona Research Center, LLC, Phoenix

85712

ACRC/Arizona Clinical Research, Tucson

Advanced Clinical Therapeutics, Tucson

92120

San Diego Arthritis and Osteoporosis Research, San Diego

92128

Scripps Clinic Rancho Bernardo, San Diego

06611

Clinical Research Consultants, Inc., Trumbull

07055

NJP Clinical Research, Passaic

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT00314652 - Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain. | Biotech Hunter | Biotech Hunter